139 related articles for article (PubMed ID: 2133234)
1. Fibrinogen Lima. A new dysfibrinogenaemia with a high-molecular-weight alpha-chain and effective polymerization.
Arocha-Piñango CL; Rodriguez S; Nagy H; Perez Requejo JL
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):561-5. PubMed ID: 2133234
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen Oviedo I. A new Spanish dysfibrinogenaemia.
Fernández FJ; Rodríguez Pinto C; Páramo J; Cuesta B; Collado M; Rocha E
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):571-5. PubMed ID: 2133236
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.
Lundberg UG; Rodriguez S; Marchi R; Ruiz-Saez A; Arocha-Piñango CL
Thromb Res; 1995 Apr; 78(2):95-106. PubMed ID: 7482436
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M
Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Stony Brook II: partial characterization of a heterozygously transmitted peptide A anomaly.
Galanakis DK; Hultin M
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):567-70. PubMed ID: 2133235
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution.
Steinmann C; Bögli C; Jungo M; Lämmle B; Heinemann G; Wermuth B; Redaelli R; Baudo F; Furlan M
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):463-71. PubMed ID: 7841300
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.
Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE
Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772
[TBL] [Abstract][Full Text] [Related]
9. Abnormal polymerization and normal binding of plasminogen and t-PA in three new dysfibrinogenaemias: Barcelona III and IV (gamma Arg 275-->His) and Villajoyosa (gamma Arg 275-->Cys).
Borrell M; Garí M; Coll I; Vallvé C; Tirado I; Soria JM; Sala N; Muñoz C; Oliver A; García A
Blood Coagul Fibrinolysis; 1995 May; 6(3):198-206. PubMed ID: 7654933
[TBL] [Abstract][Full Text] [Related]
10. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization.
Koopman J; Haverkate F; Briët E; Lord ST
J Biol Chem; 1991 Jul; 266(20):13456-61. PubMed ID: 2071611
[TBL] [Abstract][Full Text] [Related]
11. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to gamma S378P mutation.
Keller MA; Martinez J; Baradet TC; Nagaswami C; Chernysh IN; Borowski MK; Surrey S; Weisel JW
Blood; 2005 Apr; 105(8):3162-8. PubMed ID: 15632207
[TBL] [Abstract][Full Text] [Related]
13. Two novel mutations in the fibrinogen γ nodule.
Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE
Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen Adelaide: a familial hypodysfibrinogenaemia associated with abnormal alpha chains.
Exner T; Barber S; Sage RE; Kronenberg H
Br J Haematol; 1984 Jan; 56(1):95-106. PubMed ID: 6704329
[TBL] [Abstract][Full Text] [Related]
15. Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His.
Luo M; Deng D; Xiang L; Cheng P; Liao L; Deng X; Yan J; Lin F
Medicine (Baltimore); 2016 Sep; 95(39):e4864. PubMed ID: 27684817
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".
Lounes KC; Soria C; Mirshahi SS; Desvignes P; Mirshahi M; Bertrand O; Bonnet P; Koopman J; Soria J
Blood; 2000 Nov; 96(10):3473-9. PubMed ID: 11071644
[TBL] [Abstract][Full Text] [Related]
17. A hereditary dysfibrinogenemia: fibrinogen Awaji.
Matsuo T; Okuno S; Mukaida T; Ueshima S; Okada K; Matsuo O
Haemostasis; 1987; 17(1-2):89-97. PubMed ID: 3596361
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754
[TBL] [Abstract][Full Text] [Related]
19. Thrombosis-associated hypofibrinogenemia: novel abnormal fibrinogen variant FGG c.8G>A with oxidative posttranslational modifications.
Ceznerová E; Kaufmanová J; Stikarová J; Pastva O; Loužil J; Chrastinová L; Suttnar J; Kotlín R; Dyr JE
Blood Coagul Fibrinolysis; 2022 Jun; 33(4):228-237. PubMed ID: 35067535
[TBL] [Abstract][Full Text] [Related]
20. [Genotype and function analyses of four inherited dysfibrinogenemia pedigree caused by Arg16 amino acid substitution in fibrinogen Aα chain].
Jiang LL; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):475-9. PubMed ID: 22967385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
